David S. Wichmann

Insider Reports History

Reporting-owner location: Marlborough, MA
Latest reporting-owner signature: /s/ Susan Thompson, Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Transaction source note: Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for David S. Wichmann

Form 4 holding Director

Privia Health Group, Inc.

Security class: Common Stock, par value $0.01 per share
Shares / value: 1,315,340
Estimated value: $30,792,109
Report date: 21 May 2025
Price: $23.41
Ownership: Indirect

Form 4 holding Director

BOSTON SCIENTIFIC CORP

Security class: Common Stock
Shares / value: 45,382
Estimated value: $2,847,720
Report date: 07 May 2026
Price: $62.75
Ownership: Direct

Form 4 holding Director

Privia Health Group, Inc.

Security class: Common Stock, par value $0.01 per share
Shares / value: 25,709
Estimated value: $601,847
Report date: 21 May 2025
Price: $23.41
Ownership: Direct

Insider Reports Filed by David S. Wichmann

4 BSX

BOSTON SCIENTIFIC CORP

Report period: 07 May 2026
Transactions: 1
Transaction value: $0
Accepted by SEC: 11 May 2026, 16:33
Role: Director
Next action: Open filing details

4 PRVA

Privia Health Group, Inc.

Report period: 21 May 2025
Transactions: 1
Transaction value: $0
Accepted by SEC: 23 May 2025, 17:03
Role: Director
Next action: Open filing details

4 BSX

BOSTON SCIENTIFIC CORP

Report period: 08 May 2025
Transactions: 1
Transaction value: $0
Accepted by SEC: 09 May 2025, 17:35
Role: Director
Next action: Open filing details

4 PRVA

Privia Health Group, Inc.

Report period: 22 May 2024
Transactions: 1
Transaction value: $0
Accepted by SEC: 23 May 2024, 17:02
Role: Director
Next action: Open filing details

4 BSX

BOSTON SCIENTIFIC CORP

Report period: 09 May 2024
Transactions: 1
Transaction value: $0
Accepted by SEC: 13 May 2024, 16:37
Role: Director
Next action: Open filing details

4 PRVA

Privia Health Group, Inc.

Report period: 01 Aug 2023
Transactions: 1
Transaction value: $0
Accepted by SEC: 03 Aug 2023, 16:31
Role: Director
Next action: Open filing details

3 PRVA

Privia Health Group, Inc.

Report period: 01 Aug 2023
Transactions: 0
Transaction value: $0
Accepted by SEC: 03 Aug 2023, 16:30
Role: Director
Next action: Open filing details

4 BSX

BOSTON SCIENTIFIC CORP

Report period: 04 May 2023
Transactions: 1
Transaction value: $0
Accepted by SEC: 05 May 2023, 16:27
Role: Director
Next action: Open filing details

4 BSX

BOSTON SCIENTIFIC CORP

Report period: 03 Apr 2023
Transactions: 1
Transaction value: $0
Accepted by SEC: 04 Apr 2023, 19:21
Role: Director
Next action: Open filing details

4 BSX

BOSTON SCIENTIFIC CORP

Report period: 05 May 2022
Transactions: 2
Transaction value: $0
Accepted by SEC: 06 May 2022, 17:08
Role: Director
Next action: Open filing details

4 BSX

BOSTON SCIENTIFIC CORP

Report period: 15 Nov 2021
Transactions: 1
Transaction value: +$1,049,450
Accepted by SEC: 16 Nov 2021, 15:20
Role: Director
Next action: Open filing details

4 BSX

BOSTON SCIENTIFIC CORP

Report period: 01 Jul 2021
Transactions: 2
Transaction value: $0
Accepted by SEC: 06 Jul 2021, 16:12
Role: Director
Next action: Open filing details

3 BSX

BOSTON SCIENTIFIC CORP

Report period: 23 Jun 2021
Transactions: 0
Transaction value: $0
Accepted by SEC: 28 Jun 2021, 17:07
Role: Director
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .